Evidence map›Paper›PMID 19820716›Full record

ArticleNature medicine2009

Major histocompatibility complex genotyping with massively parallel pyrosequencing.

Roger W Wiseman, Julie A Karl, Benjamin N Bimber, Claire E O'Leary, Simon M Lank, Jennifer J Tuscher, Ann M Detmer, Pascal Bouffard, Natalya Levenkova, Cynthia L Turcotte and 4 more

Open access · bronzeAbstract readTechnical Report
In one paragraph

Article in Nature medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 150 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. HLA Genetics for the Human Diseases.Advances in experimental medicine and biology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Predictors of Subcutaneous Injection Site Reactions to Sustained-Release Buprenorphine in Rhesus Macaques (Journal of the American Association for Laboratory Animal Science : JAALAS · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Roger W WisemanWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Julie A Karl
Benjamin N Bimber
Claire E O'Leary
Simon M Lank
Jennifer J Tuscher
Ann M Detmer
Pascal Bouffard
Natalya Levenkova
Cynthia L Turcotte
Edward Szekeres
Chris Wright
Timothy Harkins
David H O'Connor
University of Wisconsin–Madison · USEnzo Life Sciences (United States) · USRoche (United States) · USUniversity of Illinois Urbana-Champaign · US

Funding

ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
DEVELOPMENT OF AN SPF MACACA NEMESTRINA BREEDING COLONYP40RR019995 · NCRR · JOHNS HOPKINS UNIVERSITY · PI ADAMS, ROBERT J. · 2006 to 2011
$4.9M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
Prevention of Stroke after STOP, A Retrospective Chart ReviewR01HL096789 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ADAMS, ROBERT J · 2009 to 2012
$2.7M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
NCRR NIH HHS C06 RR015459NCRR NIH HHS C06 RR020141NCRR NIH HHS P40 RR019995NCRR NIH HHS P51 RR000167NCRR NIH HHS RR020141-01NCRR NIH HHS RR15459-01NHLBI NIH HHS R01 HL096789NIAID NIH HHS HHSN266200400088C/N01-AI-40088NIAID NIH HHS N01 AI040088PHS HHS N01-A1-30061
6 · The paper itself

Abstract

Major histocompatibility complex (MHC) genetics dictate adaptive cellular immune responses, making robust MHC genotyping methods essential for studies of infectious disease, vaccine development and transplantation. Nonhuman primates provide essential preclinical models for these areas of biomedical research. Unfortunately, given the unparalleled complexity of macaque MHCs, existing methodologies are inadequate for MHC typing of these key model animals. Here we use pyrosequencing of complementary DNA-PCR amplicons as a general approach to determine comprehensive MHC class I genotypes in nonhuman primates. More than 500 unique MHC class I sequences were resolved by sequence-based typing of rhesus, cynomolgus and pig-tailed macaques, nearly half of which have not been reported previously. The remarkable sensitivity of this approach in macaques demonstrates that pyrosequencing is viable for ultra-high-throughput MHC genotyping of primates, including humans.

Indexed as

AnimalsBase SequenceDNAGenotypeHistocompatibility Antigens Class IMacaca fascicularisMacaca mulattaMacaca nemestrinaMolecular Sequence DataPolymorphism, GeneticSequence Homology, Amino AcidDNAHistocompatibility Antigens Class I

Identifiers

PMID19820716
PMCPMC2824247
OpenAlexW1990462828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.